Results 31 to 40 of about 24,578 (240)

Ultrasonographic findings of low-grade endometrial stromal sarcoma of the uterus with a focus on cystic degeneration [PDF]

Ultrasonography, 2016
Purpose: The goal of this study was to perform a retrospective analysis of the ultrasonographic findings associated with low-grade endometrial stromal sarcoma.
Ga Eun Park, Sung Eun Rha, Soon Nam Oh, Ahwon Lee, Keun Ho Lee, Mee-Ran Kim   +5 more
doaj   +1 more source

Ultrastructure of endometrial stromal sarcoma [PDF]

Cancer, 1975
An endometrial stromal sarcoma from a 48-year-old woman was studied by light and electron microscopy. Ultrastructurally most of the tumor cells resembled the stromal cells of midproliferative endometrium. There was no evidence of a pericytic differentiation of the tumor cells.
Mohammed Akhtar, Philip Y. Kim, Irving Young   +2 more
openaire   +3 more sources

Association of endometrioid ovarian carcinoma arising from endometriosis, endometrioid endometrial carcinoma, and high-grade undifferentiated endometrial sarcoma. a case report [PDF]

, 2017
Endometriosis is a chronic disease that affects women of reproductive age. Malignant transformation in endometriosis is considered to be an unusual event, only occurring in 0.7-0.1% of cases.
Caserta, D., Di Benedetto, L., Guarino, A., Mallozzi, M.   +3 more
core   +1 more source

Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series, a population-based analysis and review of the literature

Annals of Translational Medicine, 2020
Background Low-grade endometrial stromal sarcoma (LGESS) is the second most common malignant mesenchymal tumor of the uterus which usually affects young women.
Yawen Zheng, Q. Yin, Xingsheng Yang, Ruiying Dong   +3 more
semanticscholar   +1 more source

CT, MRI, and FDG-PET imaging findings of low-grade extrauterine endometrial stromal sarcoma arising from the mesentery: A case report

Radiology Case Reports, 2021
Endometrial stromal sarcoma is a rare uterine mesenchymal neoplasm, and extrauterine endometrial stromal sarcoma is even rarer, with a limited number of case reports.
Satoshi Suzuki, MD, Ryo Kurokawa, MD, PhD, Tetsushi Tsuruga, MD, PhD, Mayuyo Mori‑Uchino, MD, PhD, Haruka Nishida, MD, PhD, Tomoyasu Kato, MD, PhD, Hiroyuki Abe, MD, PhD, Tetsuo Ushiku, MD, PhD, Shiori Amemiya, MD, PhD, Akira Katayama, MD, Osamu Abe, MD, PhD   +10 more
doaj  

Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations [PDF]

, 2014
Somatic mitochondrial DNA (mtDNA) mutations have been found in a subset of endometrial cancers (EC) from different populations. We have investigated the relationship between mtDNA changes and clinical and pathological variables of women affected by ...
Bartnik, Ewa, Bryk, Jarek, Futyma, Konrad, Lorenc, Anna, Miotla, Pawel, Putowski, Lechoslaw, Semczuk, Andrzej   +6 more
core   +1 more source

A high-grade undifferentiated endometrial stromal sarcoma presenting as inversion of the uterus: A rare case

Journal of Mid-Life Health, 2020
Endometrial stromal sarcoma (ESS) is a rare malignant tumor that constitutes about 0.2% of all uterine malignancies and 10% of uterine sarcomas. ESS is generally misdiagnosed as leiomyoma or endometrial polyp and typically discovered on histopathological
Nalini Sharma, Jaya Mishra, Anusmita Saha, Aranab Kalita   +3 more
doaj   +1 more source

Case report: High-grade endometrial stromal sarcoma with adrenal glands metastases: An unreported site of metastasis

Frontiers in Oncology, 2022
BackgroundEndometrial stromal sarcoma is a relatively rare malignant tumor that derives from the malignant transformation of primitive uterine mesenchymal cells. It can lead to distant metastases. High-grade endometrial stromal sarcoma is extremely rare.
Tao Zhang, Run-lin Feng, Si-fan Yin, Wen-bo Feng, Zhi-yuan Yin, Hao Wang, Chang-Xing Ke   +6 more
doaj   +1 more source

Glucocorticoid receptor expression in 20 solid tumor types using immunohistochemistry assay. [PDF]

, 2017
BackgroundGlucocorticoid receptor (GR) activity plays a role in many aspects of human physiology and may play a crucial role in chemotherapy resistance in a wide variety of solid tumors.
Block, Thaddeus S, Lynch, Frank J, Munster, Pamela N, Murphy, Tiffany I, Nguyen, Dat P   +4 more
core   +2 more sources

Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis [PDF]

, 2015
BACKGROUND: Peritoneal metastasis (PM) is considered a terminal and incurable disease. In the last 30 years, cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) radically changed the therapeutic approach for these patients ...
Accarpio, Fabio, Biacchi, Daniele, Cardi, Maurizio, DI GIORGIO, Angelo, Mingarelli, Valentina, Musio, Daniela, Sammartino, Paolo, Sibio, Simone, Sollazzo, BIANCA MARIA   +8 more
core   +2 more sources